RADHAKISHAN PHARMACEUTICALS
KERENDIA FINERENONE TABLETS

KERENDIA FINERENONE TABLETS

MOQ : 100 Boxes

KERENDIA FINERENONE TABLETS Specification

  • Origin of Medicine
  • India
  • Indication
  • Used to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, nonfatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease associated with Type 2 Diabetes
  • Pacakaging (Quantity Per Box)
  • 30 tablets per box
  • Salt Composition
  • Finerenone
  • Dosage Form
  • Tablet
  • Drug Type
  • Allopathic
  • Ingredients
  • Finerenone
  • Physical Form
  • Tablets
  • Function
  • Nonsteroidal mineralocorticoid receptor antagonist
  • Recommended For
  • Chronic Kidney Disease (CKD) in adults with Type 2 Diabetes
  • Dosage
  • 10 mg or 20 mg once daily, as prescribed by physician
  • Dosage Guidelines
  • As Per Suggestion
  • Suitable For
  • Adults
  • Quantity
  • As required
  • Storage Instructions
  • Cool & Dry Place
  • Strength
  • 10 mg, 20 mg
  • Pack Type
  • Strip/Box
  • Prescription/Non prescription
  • Prescription
  • Side Effects
  • Possible side effects include hyperkalemia, hypotension, hyponatremia, dizziness
  • Shelf Life
  • 24 months from the date of manufacture
  • Color
  • Film-coated, yellow tablets
  • Route of Administration
  • Oral
  • Warning & Precautions
  • Not recommended during pregnancy or breastfeeding; monitor potassium levels
 

KERENDIA FINERENONE TABLETS Trade Information

  • Minimum Order Quantity
  • 100 Boxes
  • Supply Ability
  • 5000 Boxes Per Month
  • Delivery Time
  • 7 Days
  • Packaging Details
  • PACK OF 14 TABLETS.
  • Main Domestic Market
  • All India
 

About KERENDIA FINERENONE TABLETS

Description:-

Brand Name : Kerendia

Content : Finerenone Film Coated

Strength: Finerenone Film Coated 10mg

Packing : 14 Tablets

Type : Tablets

Manufactured by: Bayer Zydus...............




How KERENDIA Finerenone Tablets Work

KERENDIA acts as a nonsteroidal mineralocorticoid receptor antagonist, helping to lower excess mineralocorticoid activity in patients with chronic kidney disease related to Type 2 Diabetes. By mitigating this effect, KERENDIA can reduce risks of kidney function decline and cardiovascular complications.


Recommended Usage and Dosage

KERENDIA should be taken orally, once daily in strengths of 10 mg or 20 mg, according to the doctors prescription. Dosage may vary based on clinical evaluation and potassium levels, so ongoing monitoring is necessary for optimal safety and efficacy.

FAQs of KERENDIA FINERENONE TABLETS:


Q: How should KERENDIA Finerenone Tablets be taken for best results?

A: Take KERENDIA orally once per day at the prescribed dose of 10 mg or 20 mg. Always follow your physicians dosage instructions and do not adjust your dose independently.

Q: What are the main benefits of using KERENDIA for CKD in adults with Type 2 Diabetes?

A: KERENDIA provides significant benefit by reducing the risk of sustained reduction in kidney function, progression to end-stage kidney disease, cardiovascular death, nonfatal heart attacks, and hospitalization for heart failure.

Q: When should KERENDIA not be used or taken with caution?

A: This medicine is not recommended during pregnancy or breastfeeding and must be used with caution in patients with high potassium levels. Regular monitoring of potassium is advised while using KERENDIA.

Q: Where should KERENDIA tablets be stored to maintain their efficacy?

A: Always store KERENDIA tablets in a cool, dry place, away from moisture and heat. Ensure that they are kept in their original packaging until use and do not use them past their shelf life (24 months from manufacture).

Q: What side effects can occur while taking KERENDIA Finerenone Tablets?

A: Possible side effects include hyperkalemia (high potassium), hypotension (low blood pressure), hyponatremia (low sodium), and dizziness. These effects should be closely monitored by a healthcare provider.

Q: Who is KERENDIA suitable for and what is its primary indication?

A: KERENDIA is suitable for adult patients diagnosed with chronic kidney disease associated with Type 2 Diabetes. Its main indication is to reduce the risk of progression to kidney failure and major cardiovascular events.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Drugs & Medications Category

ALPHALAN MELPHALAN TABLETS

ALPHALAN MELPHALAN TABLETS

Minimum Order Quantity : 1 Bottle

Dosage : 2MG , 5MG

Storage Instructions : Store below 25C, protect from moisture and light

Drug Type : Other Types

Dosage Guidelines : As directed by physician

Physical Form : Tablets

Rifaxigem Rifaximin Tablets

Rifaxigem Rifaximin Tablets

Minimum Order Quantity : 1 Bottle

Dosage : 550 mg

Storage Instructions : Store in a cool, dry place below 30C. Protect from light and moisture.

Drug Type : General Medicines

Dosage Guidelines : As directed by the physician

Physical Form : Tablets

GLIZID  GLICLAZIDE AND METFORMIN TABLETS

GLIZID GLICLAZIDE AND METFORMIN TABLETS

Dosage : As directed by the physician

Storage Instructions : Store in a cool, dry place away from direct sunlight

Drug Type : Other, Combination Oral Hypoglycemic Agent

Dosage Guidelines : Take with meals or as prescribed

Physical Form : Tablets

CIMIVIR L SOFOSBUVIR AND LEDIPASVIR TABLETS

CIMIVIR L SOFOSBUVIR AND LEDIPASVIR TABLETS

Dosage : As directed by physician

Storage Instructions : Store below 30C, protected from light and moisture

Drug Type : Other, Allopathic

Dosage Guidelines : Take once daily with or without food as prescribed

Physical Form : Tablets



Back to top